未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
Brass, EP; Anthony, R; Dormandy, J; Hiatt, WR; Jiao, J; Nakanishi, A; McNamara, T; Nehler, M
分享
收藏
分享
收藏